The potential utility of (89)Zr-panitumumab in assessing HER1 status in distant metastases and understanding the variations in antibody uptake at different lesion sites is demonstrated in this study. (89)Zr-panitumumab can play a vital role in patient stratification and immunotherapy and therefore warrants further investigation for clinical translation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Radioimmune and Inorganic Chemistry Section, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. tapann [at] gmail.com
J Nucl Med. 2012 Jan;53(1):113-20
© Galenicom 1999-2013